This statistic shows the total equity of the French pharmaceutical group Ipsen from 2014 to 2019 in million euros. The group's total equity reached 1.75 billion euros in 2019. Comparatively, the total equity of Ipsen was valued 1.06 and 1.2 billion euros in 2014 and 2015. On another note, Ipsen had more than 4.3 billion euros of assets in 2019.
Total equity of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Pharmaceutical industry in Scandinavia
Pharmaceutical sales
8
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2023
- Basic Statistic Value of pharmaceutical sales in Norway 2008-2022
- Basic Statistic Value of pharmaceutical sales in Sweden 2000-2022
- Basic Statistic Sales of pharmaceuticals in Norway 2020-2021, by prescription type
- Basic Statistic Revenue of pharmaceuticals in Sweden by type 2023
- Basic Statistic Revenue of most dispensed drugs at pharmacies in Denmark 2022
- Basic Statistic Sales volume pharmaceuticals in Norway by drug category 2022
- Basic Statistic Largest pharmaceutical classes in Sweden 2023, by sales value
Patents and clinical trials
6
- Basic Statistic Number of applications for clinical trials in Denmark 2013-2021, by sponsor
- Basic Statistic Number of applications for clinical trials in Norway 2008-2021, by type of actor
- Premium Statistic Number of applications for clinical trials in Sweden 2014-2021, by sponsor
- Basic Statistic Number of biotechnology patents in Denmark 2011-2020
- Basic Statistic Number of biotechnology patents in Norway 2011-2020
- Basic Statistic Number of biotechnology patents in Sweden 2011-2020
Trade
5
- Basic Statistic Export value of medicinal and pharmaceutical products in Denmark 2010-2023
- Basic Statistic Import and export value of basic pharmaceutical products in Norway 2009-2023
- Basic Statistic Net export value of pharmaceuticals from Sweden 2012-2022
- Basic Statistic Import value of pharmaceuticals into Sweden 2012-2022
- Basic Statistic Export value of pharmaceuticals from Sweden 2012-2022
Key players
6
Further related statistics
10
- Merck & Co total assets 2009-2023
- Merck & Co - expenditure on research and development 2006-2023
- M&A capacities - changes for the global pharma industry 2008-2015
- Celgene's revenue and net income 2006-2018
- Sanofi's total assets 2007-2023
- Merck & Co cash dividends declared 2006-2023
- Pfizer's ad spending 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Sales of Johnson & Johnson 2006-2023 by region
- Revenue of Sinopharm 2011-2022, by category
Further Content: You might find this interesting as well
Statistics
- Merck & Co total assets 2009-2023
- Merck & Co - expenditure on research and development 2006-2023
- M&A capacities - changes for the global pharma industry 2008-2015
- Celgene's revenue and net income 2006-2018
- Sanofi's total assets 2007-2023
- Merck & Co cash dividends declared 2006-2023
- Pfizer's ad spending 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Sales of Johnson & Johnson 2006-2023 by region
- Revenue of Sinopharm 2011-2022, by category
Ipsen. (February 13, 2020). Total equity of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros) [Graph]. In Statista. Retrieved June 15, 2024, from https://www.statista.com/statistics/1073015/ipsen-total-equity-french-company/
Ipsen. "Total equity of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros)." Chart. February 13, 2020. Statista. Accessed June 15, 2024. https://www.statista.com/statistics/1073015/ipsen-total-equity-french-company/
Ipsen. (2020). Total equity of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros). Statista. Statista Inc.. Accessed: June 15, 2024. https://www.statista.com/statistics/1073015/ipsen-total-equity-french-company/
Ipsen. "Total Equity of The French Pharmaceutical Group Ipsen from 2014 to 2019 (in Million Euros)." Statista, Statista Inc., 13 Feb 2020, https://www.statista.com/statistics/1073015/ipsen-total-equity-french-company/
Ipsen, Total equity of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros) Statista, https://www.statista.com/statistics/1073015/ipsen-total-equity-french-company/ (last visited June 15, 2024)
Total equity of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros) [Graph], Ipsen, February 13, 2020. [Online]. Available: https://www.statista.com/statistics/1073015/ipsen-total-equity-french-company/